Skip to main content
. 2024 Jul 10;12:e17631. doi: 10.7717/peerj.17631

Figure 3. Expression levels of OR7A5 in different types of cancers.

Figure 3

(A) Analysis of the differential expression of OR7A5 in various cancer types and their corresponding adjacent tissues through TIMER2. (B) Expression levels of OR7A5 in testicular germ cell tumors (TGCT) analyzed using GEPIA. (C) Analysis of the expression status of OR7A5 in subtypes of head and neck squamous cell carcinoma (HNSC), lung squamous cell carcinoma (LUSC), and skin cutaneous melanoma (SKCM) through TISIDB. (D) Expression levels of OR7A5 in breast invasive carcinoma (BRCA) and pancreatic adenocarcinoma (PAAD) analyzed using GEPIA. (E) Enrichment scores of OR7A5 in different cancers analyzed through GSCA. (F) Analysis of signaling pathways associated with OR7A5 expression using GSCA.